Advocates, Medical Professionals, Patient Organizations, Students & Volunteers, Advocacy, Legislative Advocacy, Research & Drug Development, PDF, Publication, Education, Policy, October 17, 2022 Study on Orphan Drug Costs & Use
Advocates, Patient Organizations, Researchers, Advocacy, Research & Drug Development, PDF, Publication, Education, Policy, Orphan Drug Costs & Expenditures
Advocates, Patient Organizations, Researchers, Advocacy, Regulatory, Research & Drug Development, Collection, Publication, Education, Policy, Orphan Drug Trends in the United States 2018
Advocates, Patient Organizations, Researchers, Advocacy, Research & Drug Development, PDF, Publication, Education, Policy, Orphan Drugs in the United States: Exclusivity, Pricing and Treated Populations
Advocates, Patient Organizations, Researchers, Advocacy, Research & Drug Development, PDF, Publication, Education, Policy, Orphan Drugs in the United States: Rare Disease Innovation and Cost Trends Through 2019
Advocates, Patient Organizations, Researchers, Advocacy, Regulatory, Research & Drug Development, PDF, Publication, Education, Policy, Orphan Drugs in the United States: An Examination of Patents and Orphan Drug Exclusivity
Advocates, Patient Organizations, Students & Volunteers, Advocacy, Legislative Advocacy, Rare Disease Advisory Councils (RDAC), Educational Video, Webinar, Policy, Webinar Recording: Your State Just Enacted an RDAC – Now What?
Advocates, Patient Organizations, Students & Volunteers, Legislative Advocacy, Rare Disease Advisory Councils (RDAC), PDF, Policy, Toolkit: Advocating for a Rare Disease Advisory Council in Your State
Advocates, Patient Organizations, Students & Volunteers, Advocacy, Legislative Advocacy, RDCA-DAP, PDF, Policy, RDCA: What is it and What are its Core Components?
Advocates, Medical Professionals, Researchers, RDCA-DAP, Regulatory, Research & Drug Development, PDF, Policy, Research, Program/Agenda: Rare Disease Cures Accelerator-Data and Analytics Platform Launch
